Perioperative Anaphylaxis

Medical Clinics of North America

Volumn 94, Issue 4, 2010, Pages 761-789

  Mertes, P M ^a,b   Tajima, K ^a,b   Regnier Kimmoun, M A ^a,b   Lambert, M ^a,b   Iohom, G ^c   Gueant Rodriguez R M ^b,d   Malinovsky, J M ^e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c University College Cork and INFANT Centre   (Ireland)

^d CHU NANCY BRABOIS   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Anaphylaxis; Anesthesia; Antibiotics; Epinephrine; Latex; Neuromuscular blocking agent; Skin test; Tryptase

Indexed keywords

ADRENALIN; ALFENTANIL; ATRACURIUM; BUPIVACAINE; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CISATRACURIUM; ETOMIDATE; FENTANYL; KETAMINE; LIDOCAINE; MEPIVACAINE; MIDAZOLAM; MIVACURIUM; MORPHINE; NORADRENALIN; PANCURONIUM; PENICILLIN G; PENICILLOYL POLYLYSINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; ROPIVACAINE; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG; VANCOMYCIN; VASOPRESSIN; VECURONIUM;

ANAPHYLAXIS; ASTHMA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FLOW CYTOMETRY; FLUID THERAPY; GENERAL ANESTHESIA; HUMAN; HYPERSENSITIVITY REACTION; INCIDENCE; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RISK FACTOR; SKIN TEST;

ADRENERGIC AGONISTS; ANALGESICS, OPIOID; ANAPHYLAXIS; ANESTHESIA; ANESTHETICS, LOCAL; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APROTININ; BASOPHILS; EPINEPHRINE; FLUID THERAPY; HUMANS; HYPNOTICS AND SEDATIVES; IMMUNOGLOBULIN E; INTRAOPERATIVE COMPLICATIONS; LATEX; NEUROMUSCULAR BLOCKING AGENTS; RISK FACTORS; SERINE PROTEINASE INHIBITORS; SKIN TESTS; TRYPTASES;

EID: 77953600571     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.04.002     Document Type: Review

References (155)

1. Ishizawa Y. Mechanisms of anesthetic actions and the brain. J Anesth 21 2 (2007) 187-199
2. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 5 (2004) 832-836
3. Johansson S.G., Hourihane J.O., Bousquet J., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56 9 (2001) 813-824
4. Sampson H.A., Munoz-Furlong A., Campbell R.L., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 2 (2006) 391-397
5. Fisher M.M., and More D.G. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 9 3 (1981) 226-234
6. Laxenaire M.C. Quelle est la réalité du risqué allergique en anesthésie. Incidence. Morbidité-Mortalité. Substances responsable. Tableaux cliniques [What is the real risk of drug hypersensitivity in anesthesia? Incidence. Clinical aspects. Morbidity-mortality. Substances responsible]. Ann Fr Anesth Reanim 21 Suppl 1 (2002) 38s-54s [in French]
7. Mertes P.M., and Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 19 (2002) 240-262
8. Watkins J. Adverse anaesthetic reactions. An update from a proposed national reporting and advisory service. Anaesthesia 40 8 (1985) 797-800
9. Thienthong S., Hintong T., and Pulnitiporn A. The Thai Anesthesia Incidents Study (THAI Study) of perioperative allergic reactions. J Med Assoc Thai 88 Suppl 7 (2005) S128-S133
10. Whittington T., and Fisher M.M. Anaphylactic and anaphylactoid reactions. Clin Anaesthesiol B Clin Anaesthesiol 12 (1998) 301-323
11. Laxenaire M.C. Epidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 18 (1999) 796-809
12. Escolano F., Valero A., Huguet J., et al. Estudio epidemiológico prospectivo de perioperatorio reacciones anafilácticas se producen en Cataluña (1996-7) [Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)]. Rev Esp Anestesiol Reanim 49 6 (2002) 286-293 [in Spanish]
13. Harboe T., Guttormsen A.B., Irgens A., et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 102 5 (2005) 897-903
14. Fisher M., and Baldo B.A. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 11 4 (1994) 263-284
15. Laxenaire M., Mertes P.M., and GERAP. Anaphylaxis during anaesthesia. Results of a 2 year survey in France. Br J Anaesth 21 1 (2001) 549-558
16. Mertes P.M., Laxenaire M.C., and Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99 3 (2003) 536-545
17. Mertes P.M., and Laxenaire M.C. Les réactions anaphylactiques et anaphylactoides peranesthésiques en France. Septiéme enquête épidémiologique (Janvier 2001--Décembre 2002) [Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002)]. Ann Fr Anesth Reanim 23 12 (2004) 1133-1143 [in French]
18. Mitsuhata H., Matsumoto S., and Hasegawa J. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 41 (1992) 1664-1669
19. Light K.P., Lovell A.T., Butt H., et al. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?. Pharmacoepidemiol Drug Saf 15 3 (2006) 151-160
20. Hedin H., and Richter W. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man. Int Arch Allergy Appl Immunol 68 2 (1982) 122-126
21. Moss J. Muscle relaxants and histamine release. Acta Anaesthesiol Scand Suppl 106 (1995) 7-12
22. Jooste E.H., Sharma A., Zhang Y., et al. Rapacuronium augments acetylcholine-induced bronchoconstriction via positive allosteric interactions at the M3 muscarinic receptor. Anesthesiology 103 6 (2005) 1195-1203
23. Mertes P.M., Aimone-Gastin I., Gueant-Rodriguez R.M., et al. Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des 14 27 (2008) 2809-2825
24. Mertes P.M., Laxenaire M.C., Lienhart A., et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 15 2 (2005) 91-101
25. Kroigaard M., Garvey L.H., Gillberg L., et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 51 6 (2007) 655-670
26. Mertes P.M., Moneret-Vautrin D.A., Leynadier F., et al. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Anesthesiology 107 2 (2007) 245-252
27. Fisher M.M. The preoperative detection of risk of anaphylaxis during anaesthesia. Anaesth Intensive Care 35 6 (2007) 899-902
28. Ebo D.G., Bridts C.H., Hagendorens M.M., et al. Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 74 4 (2008) 201-210
29. Laroche D., Lefrancois C., Gerard J.L., et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 69 6 (1992) 611-614
30. Guttormsen A.B., Johansson S.G., Oman H., et al. No consumption of IgE antibody in serum during allergic drug anaphylaxis. Allergy 62 11 (2007) 1326-1330
31. Mertes P.M., and Laxenaire M.C. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 70 5 (2004) 285-291
32. Baumann A., Studnicska D., Audibert G., et al. Refractory anaphylactic cardiac arrest after succinylcholine administration. Anesth Analg 109 1 (2009) 137-140
33. Kroigaard M., Garvey L.H., Menne T., et al. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing?. Br J Anaesth 95 4 (2005) 468-471
34. Laxenaire M.C., Mouton C., Frederic A., et al. Anaphylactic shock after tourniquet removal in orthopedic surgery. Ann Fr Anesth Reanim 15 2 (1996) 179-184
35. Laroche D., Dubois F., Gérard J., et al. Radioimmunoassy for plasma histamine: a study of false positive and false negative values. Br J Anaesth 74 (1995) 430-437
36. Fisher M.M., and Baldo B.A. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 80 1 (1998) 26-29
37. Malinovsky J.M., Decagny S., Wessel F., et al. Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients. Acta Anaesthesiol Scand 52 2 (2008) 175-181
38. Baldo B.A., and Fisher M.M. Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 20 12 (1983) 1393-1400
39. Baldo B.A., and Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 306 5940 (1983) 262-264
40. Fisher M.M., and Baldo B.A. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 28 (2000) 167-170
41. Gueant J.L., Mata E., Monin B., et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 46 6 (1991) 452-458
42. Guilloux L., Ricard-Blum S., Ville G., et al. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 90 2 (1992) 153-159
43. Ebo D.G., Venemalm L., Bridts C.H., et al. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. Anesthesiology 107 2 (2007) 253-259
44. Baldo B.A., Fisher M.M., and Harle D.G. Allergy to thiopentone. Clin Rev Allergy 9 3-4 (1991) 295-308
45. Fisher M.M., Harle D.G., and Baldo B.A. Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 9 3-4 (1991) 309-318
46. Gueant J.L., Mata E., Masson C., et al. Non-specific cross-reactivity of hydrophobic serum IgE to hydrophobic drugs. Mol Immunol 32 4 (1995) 259-266
47. Hemery M.L., Arnoux B., Rongier M., et al. Correlation between former and new assays of latex IgE-specific determination using the K82 and K82 recombinant allergens from the Pharmacia Diagnostics laboratory. Allergy 60 1 (2005) 131-132
48. Ebo D.G., Fisher M.M., Hagendorens M.M., et al. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 62 5 (2007) 471-487
49. Soetens F.M. Anaphylaxis during anaesthesia: diagnosis and treatment. Acta Anaesthesiol Belg 55 3 (2004) 229-237
50. Fisher M.M., Merefield D., and Baldo B. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 82 5 (1999) 770-773
51. Levy J.H., Gottge M., Szlam F., et al. Weal and flare responses to intradermal rocuronium and cisatracurium in humans. Br J Anaesth 85 (2000) 844-849
52. Berg C.M., Heier T., Wilhelmsen V., et al. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique. Acta Anaesthesiol Scand 47 5 (2003) 576-582
53. Mertes P.M., and Laxenaire M. Anaphylaxis during general anaesthesia. Prevention and management. CNS Drugs 14 2 (2000) 115-133
54. Thacker M.A., and Davis F.M. Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant. Anaesth Intensive Care 27 2 (1999) 190-193
55. Laxenaire M.C., and Moneret-Vautrin D.A. Allergy and anaesthesia. Curr Opin Anaesthesiol 5 (1992) 436-441
56. Leynadier F., Sansarricq M., Didier J.M., et al. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 59 6 (1987) 683-689
57. Fisher M.M., and Bowey C.J. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 79 1 (1997) 59-63
58. McKinnon R.P. Allergic reactions during anaesthesia. Curr Opin Anaesthesiol 9 (1996) 267-270
59. Blanca M., Romano A., Torres M.J., et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64 2 (2009) 183-193
60. Torres M.J., Blanca M., Fernandez J., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58 10 (2003) 961-972
61. Turjanmaa K., Palosuo T., Alenius H., et al. Latex allergy diagnosis: in vivo and in vitro standardization of a natural rubber latex extract. Allergy 52 1 (1997) 41-50
62. Mertes P.M., Malinovsky J.M., Mouton-Faivre C., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 122 2 (2008) 348-352
63. Mata E., Gueant J.L., Moneret-Vautrin D.A., et al. Clinical evaluation of in vitro leukocyte histamine release in allergy to muscle relaxant drugs. Allergy 47 5 (1992) 471-476
64. Gueant J.L., Masson C., and Laxenaire M.C. Biological tests for diagnosing the IgE-mediate allergy to anaesthetic drugs. In: Assem K. (Ed). Monographs in allergy (1992), Karger, Basel 94-107
65. Bermejo N., Guéant J., Mata E., et al. Platelet serotonin is a mediator potentially involved in anaphylactic reaction to neuromuscular blocking drugs. Br J Anaesth 70 3 (1993) 322-325
66. Assem E. Release of eosinophil cationic protein (ECP) in anaphylactoid anaesthetic reactions in vivo and in vitro. Agents Actions 41 (1994) C11-C13
67. Assem E. Leukotriene C4 release from blood cells in vitro in patients with anaphylactoid reactions to neuromuscular blockers. Agents Actions 38 (1993) C242-C244
68. Abuaf N., Rajoely B., Ghazouani E., et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 104 2 Pt 1 (1999) 411-418
69. Sabbah A., Drouet M., Sainte-Laudry J., et al. Apport diagnostique de la cytométrie en flux en allergologie [Contribution of flow cytometry to allergologic diagnosis]. Allerg Immunol (Paris) 29 1 (1997) 15-21 [in French]
70. Sainte-Laudy J., Vallon C., and Guerin J.C. Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis. Allerg Immunol (Paris) 26 6 (1994) 211-214
71. Monneret G., Benoit Y., Gutowski M., et al. Detection of basophil activation by flow cytométrie in patients with allergy to muscle-relaxant drugs. Anesthesiology 92 1 (2000) 275-277
72. De Weck A.L., Sanz M.L., Gamboa P.M., et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol 18 3 (2008) 143-155
73. Prévention du risque allergique peranesthésique. Recommandations pour la pratique clinique. 2001. Available at: (2001). http://wwwsfar.org Accessed April 15, 2001
74. Bousquet P.J., Pipet A., Bousquet-Rouanet L., et al. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 38 1 (2008) 185-190
75. Demoly P., Romano A., Botelho C., et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 65 3 (2009) 327-332
76. Fisher M.M., and Bowey C.J. Alleged allergy to local anaesthetics. Anaesth Intensive Care 25 6 (1997) 611-614
77. Florvaag E., Johansson S.G., Oman H., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 49 4 (2005) 437-444
78. Garvey L.H., Roed-Petersen J., Menne T., et al. Danish Anaesthesia Allergy Centre - preliminary results. Acta Anaesthesiol Scand 45 10 (2001) 1204-1209
79. Bhananker S.M., O'Donnell J.T., Salemi J.R., et al. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg 101 3 (2005) 819-822
80. Galletly D.C., and Treuren B.C. Anaphylactoid reactions during anaesthesia. Seven years' experience of intradermal testing. Anaesthesia 40 4 (1985) 329-333
81. Heier T., and Guttormsen A.B. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand 44 7 (2000) 775-781
82. Laxenaire M.C., Gastin I., Moneret-Vautrin D.A., et al. Cross-reactivity of rocuronium with other neuromuscular blocking agents. Eur J Anaesthesiol Suppl 11 (1995) 55-64
83. Rose M., and Fisher M. Rocuronium: high risk for anaphylaxis?. Br J Anaesth 86 5 (2001) 678-682
84. Watkins J. Incidence of UK reactions involving rocuronium may simply reflect market use. Br J Anaesth 87 3 (2001) 522
85. Mertes P.M., Guttormsen A.B., Harboe T., et al. Can spontaneous adverse event reporting systems really be used to compare rates of adverse events between drugs?. Anesth Analg 104 2 (2007) 471-472
86. Laake J.H., and Rottingen J.A. Rocuronium and anaphylaxis-a statistical challenge. Acta Anaesthesiol Scand 45 10 (2001) 1196-1203
87. Florvaag E., and Johansson S.G. The pholcodine story. Immunol Allergy Clin North Am 29 3 (2009) 419-427
88. Gueant J.L., Gueant-Rodriguez R.M., Cornejo-Garcia J.A., et al. Gene variants of IL13, IL4, and IL4RA are predictors of beta-lactam allergy. J Allergy Clin Immunol 123 2 (2009) 509-510
89. Birnbaum J., and Vervloet D. Allergy to muscle relaxants. Clin Rev Allergy 9 3-4 (1991) 281-293
90. Harboe T., Johansson S.G., Florvaag E., et al. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 62 12 (2007) 1445-1450
91. Johansson S.G., Florvaag E., Oman H., et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 65 4 (2009) 498-502
92. Doenicke A.W., Czeslick E., Moss J., et al. Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg 87 2 (1998) 434-438
93. Jooste E., Klafter F., Hirshman C.A., et al. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 98 4 (2003) 906-911
94. Brown R.H., Hamilton R.G., Mintz M., et al. Genetic predisposition to latex allergy: role of interleukin 13 and interleukin 18. Anesthesiology 102 3 (2005) 496-502
95. Karila C., Brunet-Langot D., Labbez F., et al. Anaphylaxis during anesthesia: results of a 12-year survey at a French pediatric center. Allergy 60 6 (2005) 828-834
96. Niggemann B., and Breiteneder H. Latex allergy in children. Int Arch Allergy Immunol 121 2 (2000) 98-107
97. Hourihane J.O., Allard J.M., Wade A.M., et al. Impact of repeated surgical procedures on the incidence and prevalence of latex allergy: a prospective study of 1263 children. J Pediatr 140 4 (2002) 479-482
98. Rolland J.M., and O'Hehir R.E. Latex allergy: a model for therapy. Clin Exp Allergy 38 6 (2008) 898-912
99. Cremer R., Kleine-Diepenbruck U., Hering F., et al. Reduction of latex sensitisation in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg 12 Suppl 1 (2002) S19-S21
100. Cremer R., Lorbacher M., Hering F., et al. Natural rubber latex sensitisation and allergy in patients with spina bifida, urogenital disorders and oesophageal atresia compared with a normal paediatric population. Eur J Pediatr Surg 17 3 (2007) 194-198
101. Antonicelli L., Micucci C., Mistrello G., et al. Improving latex-allergy diagnosis: the clinical role of Hev b8-specific IgE. Allergy 63 5 (2008) 620-621
102. Lee M.F., Tsai J.J., Hwang G.Y., et al. Identification of immunoglobulin E (IgE)-binding epitopes and recombinant IgE reactivities of a latex cross-reacting Indian jujube Ziz m 1 allergen. Clin Exp Immunol 152 3 (2008) 464-471
103. Quercia O., Stefanini G.F., Scardovi A., et al. Patients monosensitised to Hev b 8 (Hevea brasiliensis latex profilin) may safely undergo major surgery in a normal (non-latex safe) environment. Eur Ann Allergy Clin Immunol 41 4 (2009) 112-116
104. Harper N.J., Dixon T., Dugue P., et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64 2 (2009) 199-211
105. Pichichero M.E., and Casey J.R. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 136 3 (2007) 340-347
106. Renz C.L., Thurn J.D., Finn H.A., et al. Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med 27 9 (1999) 1732-1737
107. Clarke R.S. Epidemiology of adverse reactions in anaesthesia in the United Kingdom. Klin Wochenschr 60 17 (1982) 1003-1005
108. Harle D., Baldo B., and Fisher M. The molecular basis of IgE antibody binding to thiopentone. Binding of IgE from thiopentone-allergic and non-allergic subjects. Mol Immunol 27 (1990) 853-858
109. Fisher M., Ross J., Harle D., et al. Anaphylaxis to thiopentone: an unusual outbreak in a single hospital. Anaesth Intensive Care 17 3 (1989) 361-365
110. Hofer K.N., McCarthy M.W., Buck M.L., et al. Possible anaphylaxis after propofol in a child with food allergy. Ann Pharmacother 37 3 (2003) 398-401
111. Baldo B.A., Fisher M.M., and Pham N.H. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 39 3 (2009) 325-344
112. Ring J., and Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1 8009 (1977) 466-469
113. Laxenaire M.C., Charpentier C., and Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 13 3 (1994) 301-310
114. Lorenz W., Duda D., Dick W., et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg. Lancet 343 8903 (1994) 933-940
115. Ljungstrom K.G., Willman B., and Hedin H. Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1. Ann Fr Anesth Reanim 12 2 (1993) 219-222
116. Berg E.M., Fasting S., and Sellevold O.F. Serious complications with dextran-70 despite hapten prophylaxis. Is it best avoided prior to delivery?. Anaesthesia 46 12 (1991) 1033-1035
117. Ljungstrom K.G. Dextran 40 therapy made safer by pretreatment with dextran 1. Plast Reconstr Surg 120 1 (2007) 337-340
118. Dieterich H.J., Kraft D., Sirtl C., et al. Hydroxyethyl starch antibodies in humans: incidence and clinical relevance. Anesth Analg 86 5 (1998) 1123-1126
119. Scherer K., Bircher A.J., and Figueiredo V. Blue dyes in medicine-a confusing terminology. Contact Dermatitis 54 4 (2006) 231-232
120. Cimmino V.M., Brown A.C., Szocik J.F., et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery 130 3 (2001) 439-442
121. Pevny I., and Bohndorf W. Allergie wegen Patent-blau Sensibilisierung [Group allergy due to patent blue sensitization]. Med Klin 67 20 (1972) 698-702 [in German]
122. Wohrl S., Focke M., Hinterhuber G., et al. Near-fatal anaphylaxis to patent blue V. Br J Dermatol 150 5 (2004) 1037-1038
123. Keller B., Yawalkar N., Pichler C., et al. Hypersensitivity reaction against patent blue during sentinel lymph node removal in three melanoma patients. Am J Surg 193 1 (2007) 122-124
124. White P.F. Multimodal analgesia: its role in preventing postoperative pain. Curr Opin Investig Drugs 9 1 (2008) 76-82
125. Palikhe N.S., Kim S.H., and Park H.S. What do we know about the genetics of aspirin intolerance?. J Clin Pharm Ther 33 5 (2008) 465-472
126. Kim S.H., Hur G.Y., Choi J.H., et al. Pharmacogenetics of aspirin-intolerant asthma. Pharmacogenomics 9 1 (2008) 85-91
127. Jenneck C., Juergens U., Buecheler M., et al. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol 99 1 (2007) 13-21
128. Leimgruber A. Allergische Reaktionen auf anti-inflammatorische medikamente [Allergic reactions to nonsteroidal anti-inflammatory drugs]. Rev Med Suisse 4 140 (2008) 100-103 [in German]
129. Knowles S.R., Drucker A.M., Weber E.A., et al. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity. Ann Pharmacother 41 7 (2007) 1191-1200
130. Kong J.S., Teuber S.S., and Gershwin M.E. Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Clin Rev Allergy Immunol 32 1 (2007) 97-110
131. de Weck A.L., Gamboa P.M., Esparza R., et al. Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Curr Pharm Des 12 26 (2006) 3347-3358
132. Sanz M.L., Gamboa P.M., and Mayorga C. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 9 4 (2009) 298-304
133. Bousquet P.J., Gaeta F., Bousquet-Rouanet L., et al. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des 14 27 (2008) 2792-2802
134. Viola M., Quaratino D., Gaeta F., et al. Cross-reactive reactions to nonsteroidal anti-inflammatory drugs. Curr Pharm Des 14 27 (2008) 2826-2832
135. Kober B.J., Scheule A.M., Voth V., et al. Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant. Anesth Analg 107 2 (2008) 406-409
136. Levy J.H., and Adkinson Jr. N.F. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg 106 2 (2008) 392-403
137. Dietrich W., Ebell A., Busley R., et al. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 84 4 (2007) 1144-1150
138. Garvey L.H., Kroigaard M., Poulsen L.K., et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 120 2 (2007) 409-415
139. Nybo M., and Madsen J.S. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 103 2 (2008) 192-196
140. Dunser M.W., Torgersen C., and Wenzel V. Treatment of anaphylactic shock: where is the evidence?. Anesth Analg 107 2 (2008) 359-361
141. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115 3 Suppl 2 (2005) S483-S523
142. Muraro A., Roberts G., Clark A., et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 62 8 (2007) 857-871
143. Soar J., Pumphrey R., Cant A., et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 77 2 (2008) 157-169
144. Soar J., Deakin C.D., Nolan J.P., et al. European Resuscitation Council guidelines for resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 67 Suppl 1 (2005) S135-S170
145. Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30 8 (2000) 1144-1150
146. Hussain A.M., Yousuf B., Khan M.A., et al. Vasopressin for the management of catecholamine-resistant anaphylactic shock. Singapore Med J 49 9 (2008) e225-e228
147. Kill C., Wranze E., and Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 134 3 (2004) 260-261
148. Meng L., and Williams E.L. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth 55 7 (2008) 437-440
149. Schummer C., Wirsing M., and Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 107 2 (2008) 620-624
150. Schummer W., and Schummer C. Vasopressin and suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64 7 (2009) 783
151. Schummer W., Schummer C., Wippermann J., et al. Anaphylactic shock: is vasopressin the drug of choice?. Anesthesiology 101 4 (2004) 1025-1027
152. Williams S.R., Denault A.Y., Pellerin M., et al. Vasopressin for treatment of shock following aprotinin administration. Can J Anaesth 51 2 (2004) 169-172
153. Dewachter P., Jouan-Hureaux V., Lartaud I., et al. Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats. Anesthesiology 104 4 (2006) 734-741
154. Hiruta A., Mitsuhata H., Hiruta M., et al. Vasopressin may be useful in the treatment of systemic anaphylaxis in rabbits. Shock 24 3 (2005) 264-269
155. Del Duca D., Sheth S.S., Clarke A.E., et al. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin. Ann Thorac Surg 87 2 (2009) 640-642